AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FLUCLOXACILLIN
38 registrations across 5 African markets— 27 active
Markets with FLUCLOXACILLIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FLUCLOX SUSPENSION | 🇬🇭Ghana | ESKAY THERAPEUTICS LIMITED; P.O BOX 431 DARKUMAN 42 SOUTH INDUSTRIAL AREA ACCRA, GHANA | active | Nov 2029 |
| FLUCLOX SUSPENSION | 🇬🇭Ghana | ESKAY THERAPEUTICS LIMITED; P.O BOX 431 DARKUMAN 42 SOUTH INDUSTRIAL AREA ACCRA, GHANA | active | Nov 2029 |
| EMGIFLOX ORAL SUSPENSION | 🇬🇭Ghana | — | active | Apr 2029 |
| EMGIFLOX ORAL SUSPENSION | 🇬🇭Ghana | — | active | Apr 2029 |
| EMGIFLOX ORAL SUSPENSION | 🇬🇭Ghana | — | active | Apr 2029 |
| EMGIFLOX ORAL SUSPENSION | 🇬🇭Ghana | — | active | Apr 2029 |
| Staphylex Capsule Flucloxacillin 500 mg Capsule | 🇳🇬Nigeria | Mankind Life-Sciences Limited | active | Mar 2029 |
| RONAKFLUCLOX DS SUSPENSION (Each 5ml contains Flucloxacillin 250mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| RONAKFLUCLOX DS SUSPENSION (Each 5ml contains Flucloxacillin 250mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| RONAKFLUCLOX SUSPENSION (Each 5ml contains Flucloxacillin 125mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| RONAKFLUCLOX SUSPENSION (Each 5ml contains Flucloxacillin 125mg) | 🇬🇭Ghana | — | active | Sept 2028 |
| Ethiflozin Suspension 250 mg Suspension | 🇳🇬Nigeria | SK Medicines Limited | active | Jul 2028 |
| Ethiflozin Capsules 500 mg Capsule | 🇳🇬Nigeria | SK Medicines Limited | active | Jul 2028 |
| Ethiflozin Suspension 125 mg (check composition) Suspension | 🇳🇬Nigeria | SK Medicines Limited | active | Jul 2028 |
| FLUCLOXACILLIN CAPSULES | 🇬🇭Ghana | ESKAY THERAPEUTICS LIMITED | active | May 2028 |
| FLUCLOXACILLIN CAPSULES | 🇬🇭Ghana | ESKAY THERAPEUTICS LIMITED | active | May 2028 |
| Enaflox ( Flucloxacillin 500mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| Enaflox ( Flucloxacillin 500mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| EXAFLOX INJECTION (Each vial contains Flucloxacillin 500mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| EXAFLOX INJECTION (Each vial contains Flucloxacillin 500mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| EXAFLOX INJECTION | 🇬🇭Ghana | — | active | Oct 2026 |
| EXAFLOX INJECTION | 🇬🇭Ghana | — | expired | Oct 2026 |
| Enaflox ( Flucloxacillin 500mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| EXAFLOX INJECTION | 🇬🇭Ghana | — | active | Oct 2026 |
| EXAFLOX INJECTION (Each vial contains Flucloxacillin 500mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| FLUCLOXACILLIN 250MG CAPSULES CAPSULES | 🇲🇼Malawi | — | expired | Mar 2025 |
| FLUCLOX-250 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2025 |
| FLUCANOL 500MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2023 |
| FLUCANOL 250MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2023 |
| FLUCLOXACILLIN 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2015 |
| FLUCLOXACILLIN 250MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Jun 2015 |
| F-CLODAX 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2014 |
| PHYLOPEN 250MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2011 |
| Flucoxacillin Capsules | 🇹🇿Tanzania | SPARSH BIO-TECH PRIVATE LIMITED | active | — |
| FLUCLOXACILLIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | SPARSH BIO-TECH PVT. LTD | active | — |
| FLUCLOXACILLIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | SPARSH BIO-TECH PVT LTD | active | — |
| FLUCLOXACILLIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | SPARSH BIO-TECH PVT. LTD | active | — |
| FLUCLOXACILLIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | SPARSH BIO-TECH PVT LTD | active | — |
FLUCLOXACILLIN in Africa — Regulatory Overview
FLUCLOXACILLIN is registered across 5 African markets with 38 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Nigeria, Uganda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 38 registrations, 27 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.